blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4058049

EP4058049 - POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  19.08.2022
Database last updated on 30.10.2024
FormerThe international publication has been made
Status updated on  21.05.2021
Formerunknown
Status updated on  14.11.2020
Most recent event   Tooltip22.12.2023Change - representative 
Applicant(s)For all designated states
CSL Behring Lengnau AG
Biotech Innovation Park
2543 Lengnau BE / CH
[2022/38]
Inventor(s)01 / HOFMANN, Marco
Am Schall 2
35094 Lahntal / DE
02 / BAZ MORELLI, Adriana
1106/604 Swanston St
Carlton, Victoria 3053 / AU
03 / VIKSTROM, Ingela
57 Robeson St
Preston, Victoria 3072 / AU
04 / WEIMER, Thomas
Richard-Wagner-Strasse 8
35075 Gladenbach / DE
 [2022/38]
Representative(s)Kraus & Lederer PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[N/P]
Former [2022/38]Lederer & Keller Patentanwälte Partnerschaft mbB
Unsöldstraße 2
80538 München / DE
Application number, filing date20801295.511.11.2020
[2022/38]
WO2020EP81698
Priority number, dateEP2019020825911.11.2019         Original published format: EP 19208259
[2022/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021094344
Date:20.05.2021
Language:EN
[2021/20]
Type: A1 Application with search report 
No.:EP4058049
Date:21.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 20.05.2021 takes the place of the publication of the European patent application.
[2022/38]
Search report(s)International search report - published on:EP20.05.2021
ClassificationIPC:A61K38/37, C07K14/755
[2022/38]
CPC:
C07K14/755 (EP,US); A61K38/1741 (US); A61K47/643 (EP);
C12N15/63 (US); A61K38/00 (EP); C07K2317/622 (US);
C07K2319/33 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/38]
TitleGerman:POLYPEPTIDE ZUR INDUKTION DER TOLERANZ GEGEN FAKTOR VIII[2022/38]
English:POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII[2022/38]
French:POLYPEPTIDES POUR INDUIRE UNE TOLÉRANCE AU FACTEUR VIII[2022/38]
Entry into regional phase13.06.2022National basic fee paid 
13.06.2022Designation fee(s) paid 
13.06.2022Examination fee paid 
Examination procedure13.06.2022Examination requested  [2022/38]
13.06.2022Date on which the examining division has become responsible
28.12.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
30.11.2022Renewal fee patent year 03
30.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[YD]WO2012021512  (ECOLE POLYTECH [CH], et al) [YD] 10* page 1, lines 20-26; claims 7-8 *;
 [YD]WO2013106787  (BIOGEN IDEC INC [US]) [YD] 7,8 * figure 1 *;
 [XY]WO2018234518  (CSL BEHRING LENGNAU AG [CH]) [X] 1-6,9,11-23 * claim 1 * * page 30, lines 4-25 * * page 29, lines 18-10 * * page 34, lines 1-15 * [Y] 7,8,10;
 [A]  - JAN P. NICOLAY ET AL, "Cellular stress induces erythrocyte assembly on intravascular von Willebrand factor strings and promotes microangiopathy", SCIENTIFIC REPORTS, (20181201), vol. 8, no. 1, doi:10.1038/s41598-018-28961-2, page 10945, XP055676408 [A] 1-23 * abstract *

DOI:   http://dx.doi.org/10.1038/s41598-018-28961-2
by applicantUS4399216
 EP0117060
 EP0117058
 US6403077
 WO03031464
 WO03076567
 US2004087778
 WO2004067566
 WO2004101740
 WO2005001025
 WO2005000892
 WO2005063808
 WO2006000448
 US7256253
 WO2007090584
 WO2007126808
 WO2008077616
 WO2008082669
 WO2008135501
 WO2009007451
 WO2009062100
 WO2009108806
 WO2010014708
 WO2010045568
 US2010113365
 US2010113364
 US2010168391
 US2010173831
 US2010173830
 WO2010087271
 WO2010102886
 WO2010115866
 WO2011060242
 WO2011101242
 WO2011101284
 WO2011101277
 WO2011101267
 WO2011131510
 WO2012007324
 WO2012021512
 WO2013083858
 WO2013093760
 WO2013106787
 WO2013121296
 WO2013120939
 WO2014135528
 WO2014198699
 WO2016000039
 WO2017117631
 WO2017117630
 WO2018087271
 WO2018093766
 WO2019075523
    - KONTOS S. et al., PNAS, (20120000), vol. 110, no. 1, pages E60 - E68
    - ZHOU et al., Blood, (20120000), vol. 120, no. 2, pages 449 - 458
    - SCHELLENBERGER et al., Nature Biotechnol, (20090000), vol. 27, pages 1186 - 1190
    - DUMONT J A et al., BioDrugs, (20060000), vol. 20, pages 151 - 160
    - GRAHAM et al., J. Gen Virol., (19770000), vol. 36, page 59
    - URLAUBCHASIN, Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216
    - MATHER, Biol. Reprod., (19800000), vol. 23, pages 243 - 251
    - MATHER et al., Annals NY. Acad. Sci., (19820000), vol. 383, pages 44 - 68
    - GETHING et al., Nature, (19810000), vol. 293, pages 620 - 625
    - MANTEI et al., Nature, (19790000), vol. 281, pages 40 - 46
    - Virology, (19780000), vol. 52, pages 456 - 457
    - Focus, (19930000), vol. 15, page 73
    - KEOWN et al., Methods in Enzymology, (19900000), vol. 185, pages 527 - 537
    - MANSOUR et al., Nature, (19880000), vol. 336, pages 348 - 352
    - "An Effect of Predilution on Potency Assays of FVIII Concentrates", N LEEMARTIN L et al., Thrombosis Research, Pergamon Press, (19830000), vol. 30, pages 511 - 519
    - LEE et al., Thrombosis Research, (19830000), vol. 30, pages 511 - 519
    - N LEEMARTIN L et al., An Effect of Predilution on Potency Assays of FVIII Concentrates, Thrombosis Research, Pergamon Press, (19830000), vol. 30, pages 511 - 519
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.